Top

Published in:

01-03-2021 | Magnetic Resonance Imaging | Review

Iron-containing pathologies of the spleen: magnetic resonance imaging features with pathologic correlation

Authors: Nikita Consul, Sidra Javed-Tayyab, Ajaykumar C. Morani, Christine O. Menias, Meghan G. Lubner, Khaled M. Elsayes

Published in: Abdominal Radiology | Issue 3/2021

Abstract

Systemic and non-systemic pathologies that involve iron deposition within the spleen have characteristic features on MRI due to the susceptibility properties of deposited iron, or hemosiderin. These lesions will have signal loss on longer echo sequences due to the T2* effect when evaluated with dual-echo gradient-echo sequences. The pathophysiology of systemic and localized iron sequestration disease processes can elucidate an underlying diagnosis based on these imaging features in conjunction with clinical information.

Zhang AS, Enns CA. Molecular mechanisms of normal iron homeostasis. Hematology Am Soc Hematol Educ Program. 2009:207-214. doi:https://doi.org/10.1182/asheducation-2009.1.207

Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J. Body iron metabolism and pathophysiology of iron overload. Int J Hematol. 2008;88(1):7-15. doi:https://doi.org/10.1007/s12185-008-0120-5

Jensen JH, Tang H, Tosti CL, et al. Separate MRI quantification of dispersed (ferritin-like) and aggregated (hemosiderin-like) storage iron. Magn Reson Med. 2010;63(5):1201-1209. doi:https://doi.org/10.1002/mrm.22273

Saito H. Metabolism of Iron Stores. Nagoya J Med Sci. 2014;76(3-4):235-254. doi:http://www.ncbi.nlm.nih.gov/pubmed/25741033. Accessed July 16, 2020.

Queiroz-Andrade M, Blasbalg R, Ortega CD, et al. MR imaging findings of iron overload. Radiographics. 2009;29(6):1575-1589. doi:https://doi.org/10.1148/rg.296095511

Eschbach JW, Adamson JW. Iron overload in renal failure patients: Changes since the introduction of erythropoietin therapy. Kidney Int Suppl. 1999;55(69). doi:https://doi.org/10.1046/j.1523-1755.1999.055suppl.69035.x

Shetty AS, Sipe AL, Zulfiqar M, et al. In-phase and opposed-phase imaging: Applications of chemical shift and magnetic susceptibility in the chest and abdomen. Radiographics. 2019;39(1):115-135. doi:https://doi.org/10.1148/rg.2019180043

Clark PR, Chua-anusorn W, St. Pierre TG. Proton transverse relaxation rate (R2) images of iron-loaded liver tissuepping local tissue iron concentrations with MRI. Magn Reson Med. 2003;49(3):572-575. doi:https://doi.org/10.1002/mrm.10378

Elsayes KM, Narra VR, Mukundan G, Lewis JS, Menias CO, Heiken JP. MR Imaging of the Spleen: Spectrum of Abnormalities. RadioGraphics. 2005;25(4):967-982. doi:https://doi.org/10.1148/rg.254045154

10.

Hocq A, Luhmer M, Saussez S, Louryan S, Gillis P, Gossuin Y. Effect of magnetic field and iron content on NMR proton relaxation of liver, spleen and brain tissues. Contrast Media Mol Imaging. 2015;10(2):144-152. doi:https://doi.org/10.1002/cmmi.1610

11.

Tong KA, Ashwal S, Obenaus A, Nickerson JP, Kido D, Haacke EM. Susceptibility-weighted MR imaging: A review of clinical applications in children. Am J Neuroradiol. 2008;29(1):9-17. doi:https://doi.org/10.3174/ajnr.a0786

12.

Wu EX, Kim D, Tosti CL, et al. Magnetic resonance assessment of iron overload by separate measurement of tissue ferritin and hemosiderin iron. In: Annals of the New York Academy of Sciences. Vol 1202. Blackwell Publishing Inc.; 2010:115-122. doi:https://doi.org/10.1111/j.1749-6632.2010.05587.x

13.

Shechtel JL, Petruzzi PT. The Many Uses of Chemical Shift Imaging in Body MRI. Contemp Diagnostic Radiol. 2019;42(5):1-5. doi:https://doi.org/10.1097/01.cdr.0000553492.84773.78

14.

Thomas AJ, Morani AC, Liu PS, Weadock WJ, Hussain HK, Elsayes KM. Iron-Containing Abdominal Pathologies: Exploiting Magnetic Susceptibility Artifact on Dual-Echo Gradient-Echo Magnetic Resonance Imaging. J Comput Assist Tomogr. 2019;43(2):165-175. doi:https://doi.org/10.1097/rct.0000000000000808

15.

Haque TL, Miki Y, Kanagaki M, et al. MR contrast of ferritin and hemosiderin in the brain: Comparison among gradient-echo, conventional spin-echo and fast spin-echo sequences. Eur J Radiol. 2003;48(3):230-236. doi:https://doi.org/10.1016/s0720-048x(03)00054-8

16.

Brasch RC, Wesbey GE, Gooding CA, Koerper MA. Magnetic resonance imaging of transfusional hemosiderosis complicating thalassemia major. Radiology. 1984;150(3):767-771. doi:https://doi.org/10.1148/radiology.150.3.6695078

17.

Hamilton JPA. Secondary Iron Overload - Hematology and Oncology - Merck Manuals Professional Edition. doi:https://www.merckmanuals.com/professional/hematology-and-oncology/iron-overload/secondary-iron-overload. Published 2019. Accessed March 1, 2020.

18.

Palas J, Matos AP, Ramalho M. The Spleen Revisited: An Overview on Magnetic Resonance Imaging. Radiol Res Pract. 2013;2013:1-15. doi:https://doi.org/10.1155/2013/219297

19.

Donkol RH, Monib S, Eltounsi I. Tumorlike, Iron-Sparing Foci of Splenic Hemosiderosis in a Child With Sickle Cell Anemia. J Ultrasound Med. 2006;25(12):1607-1609. doi:https://doi.org/10.7863/jum.2006.25.12.1607

20.

Singer A, Maldjian P, Simmons MZ. Extramedullary hematopoiesis presenting as a focal splenic mass: Case report. Abdom Imaging. 2004;29(6):710-712. doi:https://doi.org/10.1007/s00261-003-0164-1

21.

Kumar V, Abbas AK, Aster JC, Robbins SL. Robbins Basic Pathology. 9th ed. Philadelphia, PA: Elsevier; 2013. doi:https://www.elsevier.com/books/robbins-basic-pathology/kumar/978-1-4377-1781-5. Accessed May 16, 2020.

22.

Gabata T, Kadoya M, Mori A, Kobayashi S, Sanada J, Matsui O. MR imaging of focal splenic extramedullary hematopoiesis in polycythemia vera: Case report. Abdom Imaging. 2000;25(5):514-516. doi:https://doi.org/10.1007/s002610000045

23.

Georgiades CS, Neyman EG, Francis IR, Sneider MB, Fishman EK. Typical and Atypical Presentations of Extramedullary Hemopoiesis. Am J Roentgenol. 2002;179(5):1239-1243. doi:https://doi.org/10.2214/ajr.179.5.1791239

24.

Ricci ZJ, Mazzariol FS, Flusberg M, et al. Improving diagnosis of atraumatic splenic lesions, part II: benign neoplasms/nonneoplastic mass-like lesions. Clin Imaging. 2016;40(4):691-704. doi:https://doi.org/10.1016/j.clinimag.2016.02.002

25.

Wang Q, Ye F, Ma P, et al. Quantitative magnetic resonance imaging evaluation of hepatic fat content with iron deposition: will it be disturbed? J Int Med Res. 2019;47(5):1958-1974. doi:https://doi.org/10.1177/0300060519836033

26.

Luna A, Ribes R, Caro P, Luna L, Aumente E, Ros PR. MRI of Focal Splenic Lesions Without and With Dynamic Gadolinium Enhancement. Am J Roentgenol. 2006;186(6):1533-1547. doi:https://doi.org/10.2214/ajr.04.1249

27.

Dobritz M, Nömayr A, Bautz W, Fellner FA. Gamna-Gandy bodies of the spleen detected with MR imaging. A case report. Magn Reson Imaging. 2001;19(9):1249-1251. doi:https://doi.org/10.1016/s0730-725x(01)00451-9

28.

Zhang J, Tao R, You Z, et al. Gamna-Gandy Bodies of the Spleen Detected with Susceptibility Weighted Imaging: Maybe a New Potential Non-Invasive Marker of Esophageal Varices. PLoS One. 2013;8(1). doi:https://doi.org/10.1371/journal.pone.0055626

29.

Sagoh T, Ito K, Togashi K, et al. Gamna-Gandy bodies of the spleen: Evaluation with MR imaging. Radiology. 1989;172(3):685-687. doi:https://doi.org/10.1148/radiology.172.3.2672093

30.

Ricci ZJ, Oh SK, Chernyak V, et al. Improving diagnosis of atraumatic splenic lesions, part I: nonneoplastic lesions. Clin Imaging. 2016;40(4):769-779. doi:https://doi.org/10.1016/j.clinimag.2016.01.012

31.

Iannaccone R, Federle MP, Brancatelli G, et al. Peliosis Hepatis: Spectrum of Imaging Findings. Am J Roentgenol. 2006;187(1):W43-W52. doi:https://doi.org/10.2214/ajr.05.0167

32.

Lashbrook DJ, James RW, Phillips AJ, Holbrook AG, Agombar AC. Splenic peliosis with spontaneous splenic rupture: report of two cases. BMC Surg. 2006;6(1):9. doi:https://doi.org/10.1186/1471-2482-6-9

33.

Maves CK, Caron KH. Splenic and Hepatic Peliosis: MR Findings.; 1992. doi:www.ajronline.org. Accessed January 22, 2020.

34.

Mohandas P, Krim AOA, Samson P. Unexpected finding of splenic peliosis in a traumatic spleen in a patient with cleidocranial dysplasia. South African J Radiol. 2018;22(1). doi:https://doi.org/10.4102/sajr.v22i1.1371

35.

Kaza RK, Azar S, Al-Hawary MM, Francis IR. Primary and secondary neoplasms of the spleen. Cancer Imaging. 2010;10(1):173-182. doi:https://doi.org/10.1102/1470-7330.2010.0026

36.

Regenboog M, Bohte AE, Akkerman EM, Stoker J, Hollak CEM. Iron storage in liver, bone marrow and splenic Gaucheroma reflects residual disease in type 1 Gaucher disease patients on treatment. Br J Haematol. 2017;179(4):635-647. doi:https://doi.org/10.1111/bjh.14915

37.

Stirnemann JÔ, Belmatoug N, Camou F, et al. A review of gaucher disease pathophysiology, clinical presentation and treatments. Int J Mol Sci. 2017;18(2). doi:https://doi.org/10.3390/ijms18020441

38.

Tseng SY, Niu DM, Chu TH, et al. Very rare condition of multiple Gaucheroma: A case report and review of the literature. Mol Genet Metab Reports. 2019;20. doi:https://doi.org/10.1016/j.ymgmr.2019.100473

39.

Regenboog M, Bohte AE, Somers I, van Delden OM, Maas M, Hollak CEM. Imaging characteristics of focal splenic and hepatic lesions in type 1 Gaucher disease. Blood Cells, Mol Dis. 2016;60(4):49-57. doi:http://doi.wiley.com/10.1111/bjh.14915. Accessed January 21, 2020.

40.

Terk MR, Esplin J, Lee K, Magre G, Colletti PM. MR imaging of patients with type 1 Gaucher’s disease: Relationship between bone and visceral changes. Am J Roentgenol. 1995;165(3):599-604. doi:https://doi.org/10.2214/ajr.165.3.7645477

41.

Baris HN, Cohen IJ, Mistry PK. Gaucher disease: The metabolic defect, pathophysiology, phenotypes and natural history. Pediatr Endocrinol Rev. 2014;12(0 1):72-81./pmc/articles/PMC4520262/?report = abstract. Accessed July 16, 2020.

42.

Ivanova M, Limgala RP, Changsila E, Kamath R, Ioanou C, Goker-Alpan O. Gaucheromas: When macrophages promote tumor formation and dissemination. Blood Cells, Mol Dis. 2018;68:100-105. doi:https://doi.org/10.1016/j.bcmd.2016.10.018

43.

Kamaya A, Weinstein S, Desser TS. Multiple Lesions of the Spleen: Differential Diagnosis of Cystic and Solid Lesions. Semin Ultrasound, CT MRI. 2006;27(5):389-403. doi:https://doi.org/10.1053/j.sult.2006.06.004

44.

Ramani M, Reinhold C, Semelka RC, et al. Splenic hemangiomas and hamartomas: MR imaging characteristics of 28 lesions. Radiology. 1997;202(1):166-172. doi:https://doi.org/10.1148/radiology.202.1.8988207

45.

Rose SC, Kumpe DA, Manco-Johnson ML. Radiographic appearance of diffuse splenic hemangiomatosis. Gastrointest Radiol. 1986;11(1):342-345. doi:https://doi.org/10.1007/bf02035105

46.

Nasir A, Budhrani SS, Hafner GH, Sidawy MK, Kaiser HE. Inflammatory pseudotumor of the spleen associated with a cavernous hemangioma diagnosed at intra-operative cytology: report of a case and review of literature - PubMed. In Vivo (Brooklyn). 1999. doi:https://pubmed.ncbi.nlm.nih.gov/10218139/. Accessed July 16, 2020.

47.

Bowerson M, Menias CO, Lee K, et al. Hot spleen: hypervascular lesions of the spleen. Abdom Imaging. 2015;40(7):2796-2813. doi:https://doi.org/10.1007/s00261-015-0523-8

48.

Ricci ZJ, Kaul B, Stein MW, et al. Improving diagnosis of atraumatic splenic lesions, Part III: malignant lesions. Clin Imaging. 2016;40(5):846-855. doi:https://doi.org/10.1016/j.clinimag.2016.02.015

49.

Hamid KS, Rodriguez JA, Lairmore TC. Primary splenic angiosarcoma. JSLS J Soc Laparoendosc Surg. 2010;14(3):431-435. doi:https://doi.org/10.4293/108680810x12924466006521

50.

Thompson WM, Levy AD, Aguilera NS, Gorospe L, Abbott RM. Angiosarcoma of the Spleen: Imaging Characteristics in 12 Patients. Radiology. 2005;235(1):106-115. doi:https://doi.org/10.1148/radiol.2351040308

51.

Abbott RM, Levy AD, Aguilera NS, Gorospe L, Thompson WM. From the Archives of the AFIP. RadioGraphics. 2004;24(4):1137-1163. doi:https://doi.org/10.1148/rg.244045006

52.

Thacker C, Korn R, Millstine J, Harvin H, Van Lier Ribbink JA, Gotway MB. Sclerosing angiomatoid nodular transformation of the spleen: CT, MR, PET, and 99mTc-sulfur colloid SPECT CT findings with gross and histopathological correlation. Abdom Imaging. 2010;35(6):683-689. doi:https://doi.org/10.1007/s00261-009-9584-x

53.

Lewis RB, Lattin GE, Nandedkar M, Aguilera NS. Sclerosing Angiomatoid Nodular Transformation of the Spleen: CT and MRI Features With Pathologic Correlation. Am J Roentgenol. 2013;200(4):W353-W360. doi:https://doi.org/10.2214/ajr.12.9522

54.

Ma J, Zhang W, Wang L, et al. Imaging Features of Sclerosing Angiomatoid Nodular Transformation in Spleen. J Comput Assist Tomogr. 2019;43(6):863-869. doi:https://doi.org/10.1097/rct.0000000000000910

55.

Yuan J, Gong J. Sclerosing Angiomatoid Nodular Transformation of the Spleen (SANT): CT and MR Imaging Features of Five Cases with Pathological Correlation. Int J Radiol Radiat Oncol. 2016;2(1). doi:https://doi.org/10.17352/ijrro.000018

56.

Nakashima T, Tajima T, Mihara F, Igari T, Shida Y, Masuda T. Significance of Calcification in Sclerosing Angiomatoid Nodular Transformation: Little-Known but Meaningful Imaging Finding. J Case Reports. July 2016:325-330. doi:https://doi.org/10.17659/01.2016.0080

57.

Du J, Shen Q, Yin H, Zhou X, Wu B. Littoral cell angioma of the spleen: report of three cases and literature review. Int J Clin Exp Pathol. 2015;8(7):8516-8520. doi:http://www.ncbi.nlm.nih.gov/pubmed/26339427. Accessed July 16, 2020.

58.

Requena L, Kutzner H. Hemangioendothelioma. Semin Diagn Pathol. 2013;30(1):29-44. doi:https://doi.org/10.1053/j.semdp.2012.01.003

Title: Iron-containing pathologies of the spleen: magnetic resonance imaging features with pathologic correlation
Authors: Nikita Consul
Sidra Javed-Tayyab
Ajaykumar C. Morani
Christine O. Menias
Meghan G. Lubner
Khaled M. Elsayes
Publication date: 01-03-2021
Publisher: Springer US
Keywords: Magnetic Resonance Imaging
Magnetic Resonance Imaging
Hemangioma
Hemangioma
Hemangioma
Hemangioma
Pathology
Hemangioma
Published in: Abdominal Radiology / Issue 3/2021
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-020-02709-x

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2021

Abdominal CT in COVID-19 patients: incidence, indications, and findings

How frequently does hepatocellular carcinoma develop in at-risk patients with a negative liver MRI examination with intravenous Gadobenate dimeglumine?

Correction to: Emergency endovascular treatments for delayed hemorrhage after pancreaticobiliary surgery: indications, outcomes, and follow‑up of a retrospective cohort

Automatic semantic segmentation of kidney cysts in MR images of patients affected by autosomal-dominant polycystic kidney disease

Invited commentary: On influence and significance in quality improvement/process improvement studies

A novel identification system combining diffusion kurtosis imaging with conventional magnetic resonance imaging to assess intestinal strictures in patients with Crohn’s disease

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage